Mortality among patients with invasive group A streptococcal infections caused by the M1UK lineage: a retrospective cohort study in England and Wales

BackgroundThe M1UK sublineage of S. pyogenes has dominated post-pandemic upsurges in invasive group A streptococcal (iGAS) disease. Using a national cohort of patients with emm1 iGAS infections, we compared the case fatality rate (CFR) attributable to M1UK with ancestral emm1 lineages. MethodsWe linked emm1 S. pyogenes iGAS cases in England and Wales between December 2009-July 2022 to demographic and mortality data. We assigned lineage to isolates from 2010, 2013-2016, and 2020 using genome-sequencing or allele-specific PCR. Seven and 30-day all-cause CFR were determined for the entire cohort. Univariate and multivariate analyses were conducted to determine if lineage affected risk of death. ResultsIn total, 4,952 emm1 iGAS cases were linked with demographic and mortality data; lineage was assigned to 1,356 cases. M1UK was associated with a 30-day CFR of 24.4%, compared with 22.3% for M1global, 10.5% for M123SNP, and 10.3% for M113SNP. After adjustment for age and sex, emm1 lineage was not a significant risk factor for death within 7 or 30 days. Survival analysis highlighted rapid time to death as a feature of both M1UK and M1global. Most deaths (63.7%) occurred within 1d of diagnostic sampling. Of children under 15 who died, 56.3% died before any sampling, and 95.6% died within 1d of sampling. ConclusionsSignificant differences in mortality were not identified between M1UK and M1global but larger studies are required. Mortality due to emm1 S. pyogenes is exceptionally high. Rapid time to death has implications for clinical trials: to impact death, interventions are required prior to culture-based diagnosis.